|
|
||||||||
1Tulane Hypertension and Renal Center of Excellence and Department of Physiology, Tulane University Health Sciences Center, 2Department of Medicine/Section of Nephrology, Tulane University Health Sciences Center, and Tulane Environmental Astrobiology Center, Center for Bioenvironmental Research, 3Department of Chemistry, Xavier University of Louisiana, and 4Veterans Affairs Medical Center, New Orleans, Louisiana
Submitted 19 April 2005 ; accepted in final form 14 December 2005
Megalin is a multiligand receptor heavily involved in protein endocytosis. We recently demonstrated that megalin binds and mediates internalization of ANG II. Although there is a strong structural resemblance between ANG II and ANG-(17), their physiological actions and their affinity for the angiotensin type 1 receptor (AT1R) are dissimilar. Therefore, the hypothesis of the present work was to test whether megalin binds and internalizes ANG-(17). The uptake of ANG-(17) was determined by exposure of confluent monolayers of BN/MSV cells (a model representative of the yolk sac epithelium) to fluorescently labeled ANG-(17) (100 nM) and measurement of the amount of cell-associated fluorescence after 4 h by flow cytometry. Anti-megalin antisera and an AT1R blocker (olmesartan) were used to interfere with uptake via megalin and the AT1R, respectively. ANG-(17) uptake was prevented by anti-megalin antisera (63%) to a higher degree than olmesartan (13%) (P < 0.001). In analysis by flow cytometry of binding experiments performed in brush-border membrane vesicles isolated from kidneys of CD-1 mice, anti-megalin antisera interfered with ANG-(17) binding more strongly than olmesartan (P < 0.05 against positive control). Interactions of megalin with ANG-(17) at a molecular level were studied by surface plasmon resonance, demonstrating that ANG-(17) binds megalin dose and time dependently and with an affinity similar to ANG II. These results show that the scavenger receptor megalin binds and internalizes ANG-(17).
endocytosis; epithelial cells; angiotensin type 1 receptor; olmesartan
This article has been cited by other articles:
![]() |
M. Knipper, C. Claussen, L. Ruttiger, U. Zimmermann, R. Lullmann-Rauch, E.-L. Eskelinen, J. Schroder, M. Schwake, and P. Saftig Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis J. Physiol., October 1, 2006; 576(1): 73 - 86. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |